Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

In vitro chemotherapy testing of transitional cell carcinoma.

Publication ,  Journal Article
Shrivastav, S; Paulson, DF
Published in: Invest Urol
March 1980

The chemotherapeutic drug sensitivity of live cells freshly isolated from two human bladder tumors was studied. Substantial differences in the sensitivities of the two tumors to various chemotherapeutic drugs as well as different sensitivities of a given tumor to different drugs were found. Such data could be valuable clinically. The therapeutic value of cyclophosphamide, thiotepa and methotrexate was questionable for these two tumors because an increase in thymidine incorporation was seen after treatment with these drugs. A similar increase was observed after treatment with 5-fluorouracil in cells of a tissue-culture cell line derived from a human bladder tumor. Pretreatment of the cells with 5-fluorouracil reduced this effect. Even after 12 to 18 hours of exposure to 5-fluorouracil, the cells formed a confluent monolayer within 9 days. A similar treatment with doxorubicin hydrochloride resulted in detachment of the cells and formation of aggregates. The aggregated cells excluded trypan blue for at least 9 days after the doxorubicin hydrochloride was removed.

Duke Scholars

Published In

Invest Urol

ISSN

0021-0005

Publication Date

March 1980

Volume

17

Issue

5

Start / End Page

395 / 400

Location

United States

Related Subject Headings

  • Urinary Bladder Neoplasms
  • Thiotepa
  • Methotrexate
  • In Vitro Techniques
  • Humans
  • Fluorouracil
  • Doxorubicin
  • Dose-Response Relationship, Drug
  • Cyclophosphamide
  • Cisplatin
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shrivastav, S., & Paulson, D. F. (1980). In vitro chemotherapy testing of transitional cell carcinoma. Invest Urol, 17(5), 395–400.
Shrivastav, S., and D. F. Paulson. “In vitro chemotherapy testing of transitional cell carcinoma.Invest Urol 17, no. 5 (March 1980): 395–400.
Shrivastav S, Paulson DF. In vitro chemotherapy testing of transitional cell carcinoma. Invest Urol. 1980 Mar;17(5):395–400.
Shrivastav, S., and D. F. Paulson. “In vitro chemotherapy testing of transitional cell carcinoma.Invest Urol, vol. 17, no. 5, Mar. 1980, pp. 395–400.
Shrivastav S, Paulson DF. In vitro chemotherapy testing of transitional cell carcinoma. Invest Urol. 1980 Mar;17(5):395–400.

Published In

Invest Urol

ISSN

0021-0005

Publication Date

March 1980

Volume

17

Issue

5

Start / End Page

395 / 400

Location

United States

Related Subject Headings

  • Urinary Bladder Neoplasms
  • Thiotepa
  • Methotrexate
  • In Vitro Techniques
  • Humans
  • Fluorouracil
  • Doxorubicin
  • Dose-Response Relationship, Drug
  • Cyclophosphamide
  • Cisplatin